Impact of Donor and Recipient ST2 / IL-33 Pathway After Heart Transplantation
NCT03050892 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2017-02-13
Summary
Evaluate the association between donor soluble protein ST2 (sST2) serum levels and 30-day recipient mortality in order to improve graft screening.
Conditions
- Heart Transplant Failure and Rejection
Sponsors & Collaborators
-
Groupe Hospitalier Pitie-Salpetriere
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-29
- Primary Completion
- 2017-03-01
- Completion
- 2018-05-01
Countries
- France
Study Locations
More Related Trials
-
Acute Cardiac Dysfunction in Critical Illnes
NCT05860504 ·Status: RECRUITING
-
Metabolic Remodeling in Fontan Patients
NCT03886935 ·Status: COMPLETED
-
AOrtic Surgery: Systemic Inflammatory Response Versus Sepsis
NCT06028789 ·Status: RECRUITING
-
Responders and Non-responders in the Management of Heart Failure - Significance of Genetic Influence and Identification of Novel Informative Biomarkers
NCT06435585 ·Status: RECRUITING
-
Immunological Responses in Bovine vs Mechanical Composite Grafts
NCT04010396 ·Status: COMPLETED
-
CTO-PCI in Heart Failure Patients
NCT05632653 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Blood Based Assessment of sST2, Taken During and After Surgery, for Pediatric Patients With Heart Defects to Predict Heart Failure.
NCT07029230 ·Status: RECRUITING
-
Understanding "Heparin Resistance" in Cardiac Surgery
NCT01598883 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Clinical Scoring System and Cytokines for Prediction of Inflammatory Response in Major Surgery
NCT01353157 ·Status: COMPLETED
-
Observational Study With Additional Procedures: Metabolomic and Ultrastructural Findings of Allograft in Heart Transplantation and Their Correlation With Graft Dysfunction.
NCT07125703 ·Status: ACTIVE_NOT_RECRUITING
-
Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease
NCT00023595 ·Status: COMPLETED ·Phase: PHASE3
-
Immunometabolic Pattern of Intermittent Hypoxia During ST-segment Elevation Myocardial Infarction
NCT05230966 ·Status: UNKNOWN ·Phase: NA
-
Surgical Removal of Carotid Body in Patients With Systolic Heart Failure
NCT01653821 ·Status: COMPLETED ·Phase: NA
-
Immune Heterogeneity Before and After Cardiopulmonary Bypass in Children
NCT06214182 ·Status: COMPLETED
-
Studying Complement Inhibition in Complex Cardiac Surgery
NCT02866825 ·Status: COMPLETED ·Phase: PHASE2
-
Cardiovascular Health Study (CHS) Events Follow-up Study
NCT00149435 ·Status: COMPLETED
-
Transpulmonary Gradient After Cardiac Surgery Under Cardiopulmonary Bypass
NCT01723930 ·Status: UNKNOWN
-
Protective Monocytes and Macrophages to Limit Decompensation and Heart Damaging
NCT04022330 ·Status: UNKNOWN ·Phase: NA
-
Matrix Metalloproteinase (MMP) in Heart Failure
NCT00663494 ·Status: COMPLETED
-
Soluble ST2 and Cardiovascular Outcome
NCT04460131 ·Status: RECRUITING
-
Evaluation of Peri-operative Risk Factors for Surgery Site Infection in Cardiac Surgery
NCT02392936 ·Status: UNKNOWN
-
Assessment of the Link Between Monomeric Functional Form Plasma Level of Vasostatin-1 and Occurrence of New Onset Atrial Fibrillation in Severe Intensive Care Patients
NCT03457155 ·Status: UNKNOWN ·Phase: NA
-
Persistent Symptoms and Early Incomplete Recovery After Acute Stress-induced Cardiomyopathy: Is There Ongoing Heart Distress? The HEROIC Study
NCT02989454 ·Status: COMPLETED
-
Dynamics of Immune Map and Outcomes After On-pump Cardiac Surgery: Protocol for a Prospective Cohort Study
NCT05400356 ·Status: UNKNOWN
-
Congestive Heart Failure Surgical Treatmment With Autologous Stem Cell Therapy
NCT00480961 ·Status: UNKNOWN ·Phase: PHASE2